Clinical Trial Update: Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter [NA]

View source ↗

Summary

A Chinese University of Hong Kong study is monitoring changes in hepatic steatosis using the Continuous Controlled Attenuation Parameter (CAP) in fatty liver di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Hepatic Steatosis

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Fatty Liver | NA | Status: RECRUITING